Epac

Prosenex, a company based in Hudson, NH, specializes in the development of non-invasive screening technologies for peripheral neuropathy, particularly in patients with diabetes or at risk of diabetes. Their flagship product, the Dynamic Neuroscreening Device (DND), utilizes objective temperature and vibration discrimination testing to detect the presence of neuropathy and establish a patient baseline for future screenings.

The DND has been recognized for its innovation, being a finalist in the 2016 Diabetes Innovation Challenge and a bronze winner at the 2016 Medical Design Excellence Awards. By providing objective numerical data on sensitivity status, the device aims to enhance patient compliance with medical advice and reduce the risk of complications associated with peripheral neuropathy.

Generated from the website